Skip to content
Humanigen, Inc. episode artwork

May 9, 2018 8 min

Humanigen, Inc.

from OTCQB Podcast Hosted by OTC Markets Group

Humanigen, Inc. (OTCQB: HGEN) is a biopharmaceutical company pursuing cutting-edge science to develop our proprietary monoclonal antibodies for immunotherapy and oncology treatments. Joining our podcast today is Cameron Durrant, Chairman and CEO.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Humanigen, Inc.

0:00 8:35

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of OTCQB Podcast?

This episode is 8 minutes long.

When was this OTCQB Podcast episode published?

This episode was published on May 9, 2018.

Can I download this OTCQB Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.